The company announced results from an early-stage clinical study.
News & Analysis: Syndax Pharmaceuticals
SNDX earnings call for the period ending March 31, 2020.
Initial data from an early-stage leukemia trial is promising.
Can these sizzling biotech stocks keep the momentum going?
Traders cheer the release of a bullish note from a major investment firm.
Syndax Pharmaceuticals, Corcept Therapeutics, and LeMaitre Vascular might not be household names, but they are companies investors should get to know.